Interpreting the RAPIDO trial: factors to consider

Research output: Contribution to journal › Letter › peer-review

All Science Journal Classification (ASJC) codes

@article{6fcd566909db43baaf2aea0881302aa6,

title = "Interpreting the RAPIDO trial: factors to consider",

author = "Kumar, {Naveena A.N.}",

year = "2021",

month = mar,

doi = "10.1016/S1470-2045(21)00011-5",

language = "English",

volume = "22",

pages = "e86",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Lancet Publishing Group",

number = "3",

}

TY - JOUR

T1 - Interpreting the RAPIDO trial

T2 - factors to consider

AU - Kumar, Naveena A.N.

PY - 2021/3

Y1 - 2021/3

UR - http://www.scopus.com/inward/record.url?scp=85101718320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85101718320&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(21)00011-5

DO - 10.1016/S1470-2045(21)00011-5

M3 - Letter

AN - SCOPUS:85101718320

SN - 1470-2045

VL - 22

SP - e86

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 3

ER -